Back

DLCS 2021 - EASL-The Digital Liver Cancer Summit 2021 (Virtual Meeting)

Feb 05 - Feb 06, 2021 | GenevaSwitzerland

LARVOL is not affiliated with EASL-The Digital Liver Cancer Summit 2021 (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners

Showing 13 abstracts linked to Trials

P012 - [VIRTUAL] Comparison of Sorafenib and Lenvatinib as first line therapy in Unresectable Hepatocarcinoma: a multi-center propensity score matching analysis

  • E-Poster

P070 - [VIRTUAL] First real-life experience with atezolizumab plus bevacizumab in the treatment of advanced hepatocellular carcinoma

  • E-Poster

P091 - [VIRTUAL] Real-world experience of hepatocellular carcinoma patients after sorafenib treatment: eligibility to subsequent lines and prognostic factors.

  • E-Poster